How are interstitial lung diseases diagnosed in Germany? Results of the scientific registry for the exploration of interstitial lung diseases ("Fibrosis registry") of the WATL;Wie werden interstitielle lungenerkrankungen in Deutschland diagnostiziert? Ergebnisse des wissenschaftlichen registers zur erforschung von interstitiellen lungenerkrankungen ("Fibroseregister") der WATL

Pneumologie

Volumn 57, Issue 7, 2003, Pages 373-382

  Schweisfurth, Hans ^a,i,j   Kieslich, C ^a,j   Satake, N ^b   Loddenkemper, R ^c   Schonfeld N ^c   Mader I ^d   Treutler, D ^d   Matthiessen, W ^e   Schmidt, C ^e   Leonhardt, P ^f   Siemon, G ^g   DeWall, N ^h   Gereke, U ^a,j   Costabel, U ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b RUHRLANDKLINIK   (Germany)

^c MARTIN LUTHER KRANKENHAUS   (Germany)

^d Central Clinic Bad Berka   (Germany)

^e Fachkrankenhaus Coswig   (Germany)

^f Robert Koch Klinik   (Germany)

^g Klin Erkrankungen der Atmungsorgane   (Germany)

^h Nordwest Krankenhaus Sanderbusch   (Germany)

ⁱ CTK Cottbus   (Germany)

^j CARL THIEM KLINIKUM   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLERGIC PNEUMONITIS; ARTICLE; BRONCHIOLITIS; BRONCHOSCOPY; CANCER REGISTRY; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GERMANY; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG FIBROSIS; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; SARCOIDOSIS; TRANSBRONCHIAL BIOPSY;

BIOPSY; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; BRONCHOSCOPY; FEMALE; GERMANY; HUMANS; INCIDENCE; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; PULMONARY FIBROSIS; QUESTIONNAIRES; REGISTRIES;

EID: 0042661265     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-40557     Document Type: Article

References (33)

1. American Thoracic Society. Idiopathic pulmonary fibrosis: Diagnosis and treatment. International consensus statement. Am J Respir Crit Care Med 2000; 161: 646-664.
2. American Thoracic Society. European Respiratory Society. International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304
3. Baumgartner KB, Samet JM, Stidley CA et al. Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1997; 155: 242-248
4. Behr J. Diagnostik der idiopathischen Lungenfibrose. Pneumologie 2001; 55: 144-148
5. Bjoraker JA, Ryu JH, Edwin MK et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 157: 199-203
6. Callebaut W, Demedts M, Verleden G. Pulmonary Langerhans' cell granulomatosis (histiocytosis X) clinical analysis of 8 cases. Acta Clin Belg 1998; 53: 337-343
7. Carrington CB, Gaensler EA, Coutu RE et al. Natural history and treated course of usual and desquamative interstitial pneumonia. N Engl J Med 1978; 298: 801-809
8. Coultas DB, Zumwalt RE, Black WC et al. The epidemiology of interstitial lund diseases. Am J Respir Crit Care Med 1994; 150: 967-972
9. Crystal RG, Fulmer DJ, Roberts WC et al. Idiopathic pulmonary fibrosis: clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. Ann Intern Med 1976; 85: 769-788
10. Crystal RG et al. NHBLI workshop summery. Future research directions in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002; 166: 236-246
11. Gay SE et al. Idiopathic pulmonary fibrosis. Predicting response to therapy and survival. Am J Respir Crit Care Med 1998; 157: 1063-1072
12. Gideon NM, Mannion DM. Sarcoidosis mortality in the United States, 1979-1981: an analysis of multiple-cause mortality data. Am J Med 1996; 100: 423-427
13. Goeckenjan G. Respiratorische Bronchiolitis mit interstitieller Lungenerkrankung (RB-1LD). Pneumologie 2003; 57: 278-287
14. Green FHY. Overview of pulmonary fibrosis. Chest 2002; 122: 334-339
15. Hillerdal G, Nou E, Osterman K et al. Sarcoidosis: Epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis 1984; 130: 29-32
16. Hosoda Y, Yamaguchi M, Hiraga Y. Global epidemiology of sarcoidosis. Sarcoidosis 1997; 18: 681-694
17. Katzenstein AL, Myers JL. Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification. Am J Respir Crit Care Med 1994; 150: 77-96
18. Katzenstein AL, Myer JL. State of art. Idiopathic pulmonary fibrosis. Clinical relevance of pathologic classification. Am J Respir Crit Care Med 1986; 157: 1301-1315
19. King TE et al. Idiopathic pulmonary fibrosis. Relationship between histopathologic features and mortality. Am J Respir Crit Care Med 2001; 164: 1025-1032
20. Kirsten D. Sarkoidose in Deutschland. Pneumologie 1995; 49: 378-382
21. Kirsten D, Maganussen H. Die Diagnostik und Differentialdiagnostik der Lungensarkoidose. In: Sarkoidose Up-Date 2000 Norderstedt: BoD GmbH, 2001
22. Loddenkemper R, Kloppenborg A, Schoenfeld N et al. Clinical findings in 715 patients with newly detected pulmonary sarcoidosis - results of a cooperative study in former West Germany and Switzerland. Sarcoidosis Vasc Diffuse Lung Dis 1998; 15: 178-182
23. Marx JJ et al. Cohort studies of immunologic lung disease among Wisconsin dairy farmers. Am J Int Med 1990; 18: 263
24. Reynolds HY. Diagnostic and management strategies of diffuse interstitial lung disease. Chest 1998; 113: 192-202
25. Scharkoff T. Epidemiologie der Sarkoidose. Pneumologie 1993; 47: 588-592
26. Schönfeld N. Pulmonale Langerhans-Zell-Histiocytosis. Pneumologie 2003; 57: 159-165
27. Schweisfurth H, Costabel U, Kropp R et al. Mitteilung der Wissenschaftlichen Arbeitsgemeinschaft für die Therapie von Lungenkrankheiten (WATL): Deutsches Fibroseregister mit ersten Ergebnissen. Pneumologie 1996; 50: 899-901
28. Scott J, Johnston I, Britton J. What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. British Med J 1990; 301: 1015-1017
29. Sharma OP, Badr A. Sarcoidosis: diagnosis, staging, a newer diagnostic modalities. Clin Pulm Med 1994; 1: 223-231
30. Stack BH, Choo-Kang YF, Heard BE. The prognosis of cryptogenic fibrosing alveolitis. Thorax 1972; 27: 535-542
31. Thomeer MJ, Costabel U, Rizzato G et al. Comparison of registries of interstitial lung disease in three European countries. Eur Respir J 2001; 18, Suppl 32: 114-118
32. Turner-Warwick M, Burrows B, Johnson A. Cryptogenic fibrosing alveolitis: clinical features and their influence on survival. Thorax 1980; 35: 171-180
33. Yamaguchi M, Hosoda Y, Sasaki R et al. Epidemiological study on sarcoidosis in Japan. Recent trends in incidence and prevalence rates and changes in epidemiological features. Sarcoidosis 1989; 6: 138-146